The rising prevalence of cardiovascular diseases (CVDs) due to changed lifestyles has fueled the market for defibrillators. Lifestyle diseases such as hypertension, obesity, type 2 diabetes, and dyslipidemia are the major risk factors for CVD. CVD prevalence is also increasing due to the growing geriatric population, so the incidence of heart disease is expected to increase. During the last few years, significant improvements have been made in defibrillators. The development of subcutaneous implantable cardioverter-defibrillator (S-ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) is expected to drive market growth during the forecast period. High growth opportunities for defibrillators in emerging markets have also fueled the demand.
This report provides a brief exposure to the defibrillators global market. This report highlights the current and future market potential for this medical equipment and offers a brief analysis of the market's drivers, challenges, and opportunities. Revenues are broken down by region, type, and end user. For market estimates, data has been provided for 2019, 2020 and 2021 (as the base year), projections for 2022, and a forecast for 2027. The report also covers the market share for major market players. It includes the company profiles of the major players, with brief information about their business segments, financials, product portfolios, and recent developments. The report also provides an analysis of the impact of the COvID-19 pandemic on this market.
This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and identifies critical medical and geographical challenges and rising opportunities in the developed and developing world.
Report Includes
- A brief general outlook of the global market for defibrillators
- Analysis of current and future market potential and discussion on the market drivers, challenges, and opportunities
- Analyses of global market trends with data from 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Segmentation of the defibrillators market by type, end use and region
- Insight into the recent industry structure, regulations and policies, pipeline products, and the vendor landscape of the market leading participants
Table of Contents
Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Defibrillators
3.2 Implantable Cardioverter Defibrillators (ICDs)
3.2.1 Transvenous or Traditional ICDs
3.2.2 Subcutaneous ICDs
3.2.3 Cardiac Resynchronization Therapy-Defibrillator
3.3 External Defibrillators
3.3.1 Manual External Defibrillators
3.3.2 Automated External Defibrillators (AEDs)
3.3.3 Wearable Cardioverter Defibrillators (WCDs)
3.4 Market Drivers
3.4.1 Increasing Prevalence of the Cardiac Disorders
3.4.2 Technological Advancements in Defibrillators
3.4.3 Growing Awareness and Government Initiatives
3.5 Market Barriers
3.5.1 Technical Issues in Implantable and Automated External Defibrillators
3.5.2 Lack of Training and Awareness
3.6 Market Opportunities
3.6.1 Rise in Demand for Defibrillators in Emerging Markets
3.6.2 Impact of COVID-19 Pandemic
Chapter 4 Market Breakdown by Type
4.1 Market by Type of Defibrillator
4.1.1 Market Overview
4.1.2 Market Revenue
4.1.3 Implantable Cardioverter Defibrillators
4.1.4 External Defibrillators
Chapter 5 Market Breakdown by End User
5.1 Overview
5.2 Hospitals, Clinics and Cardiac Centers
5.3 Public Access and Pre-hospital
5.4 Home Care
Chapter 6 Market Breakdown by Region
6.1 Introduction
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Competitive Landscape
7.1 Mergers, Acquisitions, and Collaborations
7.1.1 Recent Developments in the Market for Defibrillators
7.1.2 Defibrillator Market Shares
7.1.3 FDA approvals for Premarket AEDs in 2019, 2020 and 2021
7.1.4 Recent Product Recalls
Chapter 8 Company Profiles
- Abbott Laboratories
- Asahi Kasei Corp.
- Biotronik Se & Co. Kg
- Boston Scientific Corp.
- Defibtech Llc
- Livanova
- Mediana
- Medtronic Plc
- Nihon Kohden Corp.
- Philips Medical Corp.
- Stryker Corp.
Chapter 9 Project Scope and Methodology
9.1 Scope of Report
9.2 Methodology
9.3 Analyst's Credentials
9.4 Custom Research
9.5 Related Research Reports
List of Tables
Summary Table: Global Market for Defibrillators, by Type, Through 2027
Table 1: Global Market for Defibrillators, by Type, Through 2027
Table 2: Global Market for Implantable Cardioverter Defibrillators, by Region, Through 2027
Table 3: Global Market for Implantable Cardioverter Defibrillators, by Type, Through 2027
Table 4: Global Market for External Defibrillators, by Region, Through 2027
Table 5: Global Market for External Defibrillators, by Type, Through 2027
Table 6: Global Market for Defibrillators, by End User, Through 2027
Table 7: Global Market for Defibrillators in Hospitals, Clinics, and Cardiac Centers, by Region Through 2027
Table 8: Global Market for Public Access and Pre-hospital Defibrillators, by Region, Through 2027
Table 9: Global Market for Home Care Defibrillators,, by Region, Through 2027
Table 10: Global Market for Defibrillators, by Region, Through 2027
Table 11: North American Market for Defibrillators, by Type, Through 2027
Table 12: European Market for Defibrillators, by Type, 2019-2027
Table 13: Asia-Pacific Market for Defibrillators, by Type, 2019-2027
Table 14: Rest of the World Market for Defibrillators, by Type, 2019-2027
Table 15: Mergers and Acquisitions in the Defibrillator Market, 2019-2022
Table 16: FDA Premarket Approvals for Defibrillators, 2019-2022
Table 17: Recent Product Recalls, 2019-2022
Table 18: Abbott: Financial Performance, 2019-2021
Table 19: Asahi Kasei Corp.: Business Segments
Table 20: Asahi Kasei Corp.: Financial Performance, 2019-2021
Table 21: Biotronik: Business Segments
Table 22: Boston Scientific Corp.: Business Segments
Table 23: Boston Scientific Corp.: Financial Performance, 2019-2021
Table 24: LivaNova plc: Business Segments
Table 25: LivaNova plc: Financial Performance, 2019-2021
Table 26: Mediana: Business Segments
Table 27: Medtronic plc: Business Segments
Table 28: Medtronic plc: Financial Performance, 2019-2021
Table 29: Nihon Kohden: Business Segments
Table 30: Nihon Kohden: Financial Performance, 2019-2021
Table 31: Philips Medical Corp.: Business Segments
Table 32: Philips Medical Corp.: Financial Performance, 2019-2021
Table 33: Stryker Corp.: Business Segments
Table 34: Stryker Corp.: Financial Performance, 2019-2021
List of Figures
Summary Figure: Global Market for Defibrillators, by Type, 2019-2027
Figure 1: Global Market for Defibrillators, by Type, 2019-2027
Figure 2: Global Market Share of Defibrillators, by Type, 2021
Figure 3: Global Market for Implantable Cardioverter Defibrillators, by Region, 2019-2027
Figure 4: Global Market for Implantable Cardioverter Defibrillators, by Type, 2019-2027
Figure 5: Global Market for External Defibrillators, by Region, 2019-2027
Figure 6: Global Market for External Defibrillators, by Type, 2019-2027
Figure 7: Global Market for Defibrillators, by End User, 2019-2027
Figure 8: Global Market for Defibrillators in Hospital, Clinics, and Cardiac Centers, by Region, 2019-2027
Figure 9: Global Market for Public Access and Pre-hospital Defibrillators, by Region, 2019-2027
Figure 10: Global Market for Home Care Defibrillators, by Region, 2019-2027
Figure 11: Global Market for Defibrillators, by Region, 2019-2027
Figure 12: Global Market Share of Defibrillators, by Region, 2021
Figure 13: North American Market for Defibrillators, by Type, 2019-2027
Figure 14: European Market for Defibrillators, by Type, 2019-2027
Figure 15: Asia-Pacific Market for Defibrillators, by Type, 2019-2027
Figure 16: Rest of the World Market for Defibrillators, by Type, 2019-2027
Figure 17: Global Market Share of Defibrillators, by Key Manufacturer, 2021
Figure 18: Abbott: Annual Revenue, 2019-2021
Figure 19: Abbott: Net Sales, by Business Segment, 2021
Figure 20: Abbott: Net Sales, by Region, 2021
Figure 21: Asahi Kasei Corp.: Annual Revenue, 2019-2021
Figure 22: Asahi Kasei Corp.: Net Sales, by Business Segment, 2021
Figure 23: Asahi Kasei Corp.: Net Sales, by Region, 2021
Figure 24: Boston Scientific Corp.: Annual Revenue, 2019-2021
Figure 25: Boston Scientific Corp.: Net Sales, by Business Segment, 2021
Figure 26: Boston Scientific Corp.: Net Sales, by Region, 2021
Figure 27: LivaNova plc: Annual Revenue, 2019-2021
Figure 28: LivaNova plc: Net Sales, by Business Segment, 2021
Figure 29: LivaNova plc: Net Sales, by Region, 2021
Figure 30: Medtronic plc: Annual Revenue, 2019-2021
Figure 31: Medtronic plc: Net Sales, by Business Segment, 2021
Figure 32: Medtronic plc: Net Sales, by Region, 2021
Figure 33: Nihon Kohden: Annual Revenue, 2019-2021
Figure 34: Nihon Kohden: Net Sales, by Business Segment, 2021
Figure 35: Nihon Kohden: Total Revenue, by Region, 2021
Figure 36: Philips Medical Corp.: Annual Revenue, 2019-2021
Figure 37: Philips Medical Corp.: Net Sales, by Business Segment, 2021
Figure 38: Philips Medical Corp.: Net Sales, by Region, 2021
Figure 39: Stryker Corp.: Annual Revenue, 2019-2021
Figure 40: Stryker Corp.: Net Sales, by Business Segment, 2021
Figure 41: Stryker Corp.: Net Sales, by Region, 2021
Executive Summary
Defibrillators are used to maintain or restore a regular heartbeat in someone who has experienced a heart attack, stroke or irregular heartbeat. Today, defibrillator makers are focusing on producing automated external defibrillators, wearable cardioverter defibrillators and ICDs. The market has witnessed many new product approvals. Millions of ICD and CRT-D implant procedures are performed yearly in hospitals, clinics and cardiac centers. The global defibrillators market is also growing due to significant sales of automated external defibrillators (AEDs) and wearable cardioverter defibrillators (WCDs). These are now found in airports, community centers, schools, government buildings, hospitals, and other public locations.
The growing prevalence of CVDs will be the key factor of market growth during the forecast period. Secondly, technological advancements such as the introduction of new devices with simplified implantation technology, smaller size, and reduced or eliminated leads are also driving the market growth. In addition, the growing geriatric population worldwide, growing healthcare expenditures especially in the Asia-Pacific region, government initiatives, and support for the use of AEDs in public places will contribute to the growth of the market during the forecast period. The major players in the market are Medtronic plc, Abbott Laboratories, Philips Medical Corp., Stryker, Boston Scientific Corp., and Zoll Corp.
This report segments the defibrillators market by type, application, end user, and region. Based on the type, the market is segmented into implantable cardioverter defibrillators and external cardioverter defibrillators. The implantable cardioverter defibrillators segment has the highest share in the market; leading products includes the Entrant HF CRT-D, Entrant ICD, Gallant ICD, and Quadra Assura MP CRT-D (all from Abbott Laboratories). Some major AEDs are the HeartStart HS AED and HeartStart FRx AED (Philips); Propaq M, Propaq MD and X Series defibrillators from Asahi Kasei; Resonate family of CRT-Ds and Dynagen X4 CRT-D from Boston Scientific; Platinum Lifeline ARM from LivaNova; and A-16 AED by Mediana. Based on application, the implantable cardioverter defibrillators market is segmented into cardiac resynchronization therapy defibrillators (CRT-D), subcutaneous implantable cardioverter defibrillators (S-ICD), and transvenous cardioverter defibrillators (T-ICD), and the external defibrillators market is segmented into manual external defibrillators, automated external defibrillators and wearable cardioverter defibrillators. Based on end user, the market is segmented into hospitals, clinics and cardiac centers; public access and pre-hospital; and home care
Companies Mentioned
- Abbott Laboratories
- Asahi Kasei Corp.
- Biotronik Se & Co. Kg
- Boston Scientific Corp.
- Defibtech Llc
- Livanova
- Mediana
- Medtronic Plc
- Nihon Kohden Corp.
- Philips Medical Corp.
- Stryker Corp.
